Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial
口服法匹拉韦治疗 COVID-19 的临床疗效、安全性和病毒致突变性:一项基于社区的、开放标签的随机 III 期试验的结果
期刊:Antimicrobial Agents and Chemotherapy
影响因子:
doi:10.1128/aac.00054-25
Tate, Matthew; Illingworth, Christopher J R; MacGregor, Gordon; Cunningham, Laura; Divers, Laura; McCartney, Elaine; Paterson, Lucy; Kelly, Caroline; Shaw, Ann; Perkins, Jonathan S; Silva, Vanessa; Holland, Poppy; Dalton, Carol; Carmichael, Samantha; Douglas, Elizabeth; Surtees, Pamela; Scott, Janet T; Berry, Colin; Vattipally, Sreenu; Da Silva Filipe, Ana; Tong, Lily; Gunson, Rory; McInnes, Iain B; Jones, Robert; Thomson, Emma; Blyth, Kevin G